Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 92,865 | 76,896 | 116,216 | 206,492 | 46,795 |
| Marketable Securities | 319,504 | 199,344 | 235,651 | 98,680 | 9,077 |
| Receivables | N/A | N/A | N/A | N/A | 113 |
| Inventories | N/A | N/A | 936 | 0 | N/A |
| TOTAL | $419,809 | $287,254 | $393,183 | $322,201 | $60,743 |
| Non-Current Assets | |||||
| PPE Net | 6,400 | 5,630 | 7,076 | 1,974 | 1,160 |
| Investments And Advances | 0 | 222 | 865 | 75,840 | 0 |
| Other Non-Current Assets | 30 | 10,030 | 8,030 | 12 | 2,456 |
| TOTAL | $6,430 | $15,882 | $15,971 | $77,826 | $3,616 |
| Total Assets | $426,239 | $303,136 | $409,154 | $400,027 | $64,359 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,945 | 7,471 | 10,361 | 4,727 | 1,911 |
| Accrued Expenses | 19,217 | 15,803 | 15,437 | 7,583 | 2,963 |
| TOTAL | $28,236 | $23,366 | $25,890 | $12,372 | $5,009 |
| Non-Current Liabilities | |||||
| Long Term Debt | 182,104 | 0 | N/A | N/A | N/A |
| Deferred Revenues | 74 | 92 | 92 | 62 | 135 |
| Other Non-Current Liabilities | 1,658 | 0 | 0 | 0 | 0 |
| TOTAL | $184,272 | $495 | $481 | $138 | $193 |
| Total Liabilities | $212,508 | $23,861 | $26,371 | $12,510 | $5,202 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,500 | 67,845 | 50,409 | 43,757 | 37,924 |
| Common Shares | 7 | 7 | 5 | 4 | 3 |
| Retained earnings | -963,938 | -667,509 | -378,630 | -222,376 | -136,906 |
| Other shareholders' equity | 102,699 | -92 | -48 | -501 | -22 |
| TOTAL | $213,731 | $279,275 | $382,783 | $387,517 | $59,157 |
| Total Liabilities And Equity | $426,239 | $303,136 | $409,154 | $400,027 | $64,359 |